Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapy.

ESMO Open · 2025 · PMC12554025 · PMID 41106018

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

showed a trendP = 0.051so close (0.05 < p ≤ 0.1)

Luminal A tumors ( n = 93) had higher response rates than Luminal B tumors ( n = 43), (86.0% versus 69.8%; P = 0.047) and showed a trend toward higher CCCA rates (47.3% versus 27.9%; P = 0.051) ( Figure 1 C).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.